Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,719
archived clinical trials in
Diabetic Neuropathy

The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
PAB Clinical Research
mi
from
Brandon, FL
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
PAB Clinical Research
mi
from
Brandon, FL
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Renstar Medical Research
mi
from
Ocala, FL
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Suncoast Clinical Research
mi
from
Palm Harbor, FL
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Suncoast Clinical Research
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Florida Medical Clinic
mi
from
Wesley Chapel, FL
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Florida Medical Clinic
mi
from
Wesley Chapel, FL
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
North Chattahoochee Family Physicians LLC
mi
from
Johns Creek, GA
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
North Chattahoochee Family Physicians LLC
mi
from
Johns Creek, GA
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Willis-Knighton Physician Network / WKB Family Medicine Associates
mi
from
Bossier City, LA
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Willis-Knighton Physician Network / WKB Family Medicine Associates
mi
from
Bossier City, LA
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Tulane University School of Medicine
mi
from
New Orleans, LA
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Tulane University School of Medicine
mi
from
New Orleans, LA
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Urgent Care Specialists, LLC dba Hometown Urgent Care & Occupational Health
mi
from
Dayton, OH
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Urgent Care Specialists, LLC dba Hometown Urgent Care & Occupational Health
mi
from
Dayton, OH
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
CRI Lifetree
mi
from
Philadelphia, PA
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
CRI Lifetree
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Trinity Clinical Research
mi
from
Tullahoma, TN
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Trinity Clinical Research
mi
from
Tullahoma, TN
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
FutureSearch Trials of Neurology, LP
mi
from
Austin, TX
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
FutureSearch Trials of Neurology, LP
mi
from
Austin, TX
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Centex Studies Inc
mi
from
Houston, TX
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Centex Studies Inc
mi
from
Houston, TX
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Northeast Clinical Research of San Anotnio, LLC
mi
from
Schertz, TX
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Northeast Clinical Research of San Anotnio, LLC
mi
from
Schertz, TX
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
ClinPoint Trials, LLC
mi
from
Waxahachie, TX
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
ClinPoint Trials, LLC
mi
from
Waxahachie, TX
Click here to add this to my saved trials
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  1/15/2016
Strelitz Diabetes Center
mi
from
Norfolk, VA
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Nutritional Benefits of Metanx® in Subjects With Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 1/15/2016
Strelitz Diabetes Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy
Evaluation of the Effect of Intensive Diabetes Control Through Non-Surgical Intensive Lifestyle Modifications and Weight Reduction on Diabetic Peripheral Neuropathy
Status: Enrolling
Updated:  2/22/2016
Joslin Diabetes Center
mi
from
Boston, MA
Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy
Evaluation of the Effect of Intensive Diabetes Control Through Non-Surgical Intensive Lifestyle Modifications and Weight Reduction on Diabetic Peripheral Neuropathy
Status: Enrolling
Updated: 2/22/2016
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#157)
mi
from
Birmingham, AL
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#157)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#130)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#145)
mi
from
Prescott, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#145)
mi
from
Prescott, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#142)
mi
from
Tucson, AZ
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#142)
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#160)
mi
from
Los Angeles, CA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#160)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Riverside, CA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#159)
mi
from
Roseville, CA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#159)
mi
from
Roseville, CA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#153)
mi
from
Arvada, CO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#153)
mi
from
Arvada, CO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#118)
mi
from
Aurora, CO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#118)
mi
from
Aurora, CO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Westminster, CO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Westminster, CO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#158)
mi
from
Waterbury, CT
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#158)
mi
from
Waterbury, CT
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#156)
mi
from
Columbus, GA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#156)
mi
from
Columbus, GA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Chicago, IL
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Michigan City, IN
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Michigan City, IN
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#115)
mi
from
New Orleans, LA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#115)
mi
from
New Orleans, LA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#147)
mi
from
Greenbelt, MD
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#147)
mi
from
Greenbelt, MD
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#117)
mi
from
Boston, MA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#117)
mi
from
Boston, MA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Springfield, MA
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Springfield, MA
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Detroit, MI
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#134)
mi
from
Pontiac, MI
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#134)
mi
from
Pontiac, MI
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#152)
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#141)
mi
from
Las Vegas, NV
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#141)
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#128)
mi
from
Buffalo, NY
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#128)
mi
from
Buffalo, NY
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#136)
mi
from
Northport, NY
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#136)
mi
from
Northport, NY
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#154)
mi
from
West Nyack, NY
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#154)
mi
from
West Nyack, NY
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Asheville, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site
mi
from
Charlotte, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#125)
mi
from
Durham, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#125)
mi
from
Durham, NC
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#155)
mi
from
New Bern, NC
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#155)
mi
from
New Bern, NC
Click here to add this to my saved trials